跳至主要内容
临床试验/CTRI/2023/02/050079
CTRI/2023/02/050079已完成未知

Efficacy and safety of Zoledronic acid as an add on therapy to vitamin D3 in patients of stress fracture of lower limb

PT BD SHARMA PGIMS ROHTAK0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1-patients between 18 to 45 years of age.
  • 2- patients newly diagnosed as having stress fracture.
  • 3- patients having MRI evidence of stress fracture as per TSI grading 1 to 2.
  • 4- patients willing to give written informed consent.
  • 5- patients with low level of vitamin d3 then normal.

排除标准

  • 1. MRI grade 3 and 4 for stress fracture as per TSI grading.
  • 2. Patients who have received any intraarticular injection of zoledronic acid at least 3 months before the study.
  • 3. Patients with known hypersensitivity to study drugs.
  • 4. Patients with severe renal insufficiency or hepatic disease.
  • 5. Pregnant females.
  • 6. Patients who refused to give informed consent.
  • 7. Patients older than 45 years of age
  • 8. Patients with osteoporosis
  • 9. Patients with pathological fractures

研究者

发起方
PT BD SHARMA PGIMS ROHTAK

相似试验